Innovent Biologics up 10%
Innovent Biologics rises on Pfizer collaboration deal worth up to $10.5 billion to develop oncology medicines. Partnership aims to develop new cancer treatments.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.